Prospective Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. Sep 28, 2015; 21(36): 10443-10452
Published online Sep 28, 2015. doi: 10.3748/wjg.v21.i36.10443
Table 2 Overall curative effect based on mRECIST criteria n
Chemoembolizationgroup (n = 39)Chemoembolization + HAICgroup (n = 45)P-value
CR512
PR1219
SD98
PD116
Not evaluated2 (lost)0
ORR17/37 (45.9%)31/45 (68.9%)0.036
DCR26/37 (70.3%)39/45 (86.7%)0.068